Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kulke

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Plos One|September 15, 2020
Cancer stage at presentation for incarcerated patients at a single urban tertiary care centerKathryn I Sunthankar, Kevin N Griffith, Stephanie D Talutis, et al.
Neuroendocrinology|May 1, 2015
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical AspectsAnna Koumarianou, Gregory Kaltsas, Matthew H Kulke, et al.
Cancer|July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S Fuchs, Jeffrey W Clark, David P Ryan, et al.
Digestive Diseases and Sciences|July 26, 2006
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumorsMatthew H Kulke, Bingyan Wu, David P Ryan, et al.
Cancer Chemotherapy and Pharmacology|October 21, 2010
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumorsMatthew H Kulke, Jennifer A Chan, Jeffrey A Meyerhardt, et al.
American Journal of Clinical Oncology|February 8, 2006
The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancerA David McCollum, Bingyan Wu, Jeffrey W Clark, et al.
The Oncologist|June 22, 2005
A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinomaAndrew X Zhu, Charles S Fuchs, Jeffrey W Clark, et al.
Endocrine-Related Cancer|March 4, 2008
Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysisEva-Maria Duerr, Yusuke Mizukami, Aylwin Ng, et al.
Clinical Therapeutics|April 5, 2016
Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview ApproachHeather L Gelhorn, Matthew H Kulke, Thomas O'Dorisio, et al.
Digestive Diseases and Sciences|June 29, 2007
Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancerJeffrey A Meyerhardt, Andrew X Zhu, Keith Stuart, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Plos One|September 15, 2020
Cancer stage at presentation for incarcerated patients at a single urban tertiary care centerKathryn I Sunthankar, Kevin N Griffith, Stephanie D Talutis, et al.
Neuroendocrinology|May 1, 2015
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical AspectsAnna Koumarianou, Gregory Kaltsas, Matthew H Kulke, et al.
Cancer|July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S Fuchs, Jeffrey W Clark, David P Ryan, et al.
Digestive Diseases and Sciences|July 26, 2006
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumorsMatthew H Kulke, Bingyan Wu, David P Ryan, et al.
Cancer Chemotherapy and Pharmacology|October 21, 2010
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumorsMatthew H Kulke, Jennifer A Chan, Jeffrey A Meyerhardt, et al.
American Journal of Clinical Oncology|February 8, 2006
The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancerA David McCollum, Bingyan Wu, Jeffrey W Clark, et al.
The Oncologist|June 22, 2005
A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinomaAndrew X Zhu, Charles S Fuchs, Jeffrey W Clark, et al.
Endocrine-Related Cancer|March 4, 2008
Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysisEva-Maria Duerr, Yusuke Mizukami, Aylwin Ng, et al.
Clinical Therapeutics|April 5, 2016
Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview ApproachHeather L Gelhorn, Matthew H Kulke, Thomas O'Dorisio, et al.
Digestive Diseases and Sciences|June 29, 2007
Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancerJeffrey A Meyerhardt, Andrew X Zhu, Keith Stuart, et al.
Pageof 19